Beyond survival: addressing sexual health in advanced prostate cancer care.

Dear Editor, The therapeutic landscape of prostate cancer (PCa) has changed considerably over the last decade, with clear improvements in diagnosis, including PSMA PET and fusion biopsies, treatment options, and survival. Consequently, a growing number of patients are now living longer after their PCa initial diagnosis, and increasing attention is progressively shifting toward long-term quality of life. In Italy, men living after a diagnosis of prostate cancer increased from 217,000 in 2014 to 485,000 in 2024, with a five-year survival rate of approximately 91% [...].